| 翻訳と辞書 |
| Regulation of genetic engineering ： ウィキペディア英語版 |
Regulation of genetic engineering
The regulation of genetic engineering begins before the experiment has started with approval processes, through to protocols that must be followed in the laboratory and finally the conditions under which the resultant product may be released. These regulations vary from country to country, particularly when it comes to the release of any genetically modified organism. Europe does not have a single policy but a patchwork of policies at international, Community, Member State and local levels.
==History==
The development of a regulatory framework concerning genetic engineering began in 1975, at Asilomar, California. The first use of Recombinant DNA (rDNA) technology had just been successfully accomplished by Stanley Cohen and Herbert Boyer two years previously and the scientific community recognized that as well as benefits this technology could also pose some risks. The Asilomar meeting recommended a set of guidelines regarding the cautious use of recombinant technology and any products resulting from that technology. The Asilomar recommendations were voluntary, but in 1976 the US National Institute of Health (NIH) formed a rDNA advisory committee. This was followed by other regulatory offices (the United States Department of Agriculture (USDA), Environmental Protection Agency (EPA) and Food and Drug Administration (FDA)), effectively making all rDNA research tightly regulated in the USA. In 1982 the Organization for Economic Co-operation and Development (OECD) released a report into the potential hazards of releasing genetically modified organisms into the environment as the first transgenic plants were being developed. As the technology improved and genetically organisms moved from model organisms to potential commercial products the USA established a committee at the Office of Science and Technology (OSTP) to develop mechanisms to regulate the developing technology.〔 In 1986 the OSTP assigned regulatory approval of genetically modified plants in the US to the USDA, FDA and EPA.
The Cartagena Protocol on Biosafety was adopted on 29 January 2000 and entered into force on 11 September 2003.〔http://bch.cbd.int/protocol/background/〕 It is an international treaty that governs the transfer, handling, and use of genetically modified (GM) organisms. It is focussed on movement of GMOs between countries and has been called a de facto trade agreement. One hundred and fifty-seven countries are members of the Protocol and many use it as a reference point for their own regulations.〔http://www.agbioforum.org/v13n3/v13n3a02-gruere.htm#R13〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Regulation of genetic engineering」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|